PI3Kα-IN-22
PI3Kα-IN-22 (Compound 17) is a potent, selective, and orally bioavailable inhibitor specifically targeting the oncogenic PI3Kα H1047R mutant. With an IC50 of 1 nM in cellular assays, it has shown promising antitumor efficacy, including tumor regression in the HCC1954 xenograft model, supporting its use in cancer research.
Product Specifications
CAS Number
2925030-26-6
Field of Research
Signal Transduction
Smiles
[C@@H] (NC1=C (C (O) =O) C=CC=C1) (C) C=2C=3N (C (=O) C (C#N) =C (N3) N4CCC (F) (F) CC4) C=C (C) C2
Molecular Formula
C24H23F2N5O3
Molecular Weight
467.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
320199-01 50 µg
IL-6 (IL6, IFNB2, Interleukin-6, IL-6, B-cell stimulatory factor 2, BSF-2, CTL differentiation factor, CDF, Hybridoma growth factor, Interferon beta-2, IFN-beta-2)
Sign In for Pricing
View Details 320199-02 100 µg
IL-6 (IL6, IFNB2, Interleukin-6, IL-6, B-cell stimulatory factor 2, BSF-2, CTL differentiation factor, CDF, Hybridoma growth factor, Interferon beta-2, IFN-beta-2)
Sign In for Pricing
View Details 